In conclusion, our meta-analysis suggested that XRCC1 Arg194Trp and Arg399Gln polymorphisms may be associated with overall survival and response to platinum-based chemotherapy in lung cancer patients. This evidence concerns the gene XRCC1 and lung cancer.